EMEA (Europe, Middle East and Africa) Narcolepsy Therapeutics Industry 2017 Market Research Report

Published: Nov, 2017 | Pages: 102 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, the EMEA Narcolepsy Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Narcolepsy Therapeutics for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Narcolepsy Therapeutics market competition by top manufacturers/players, with Narcolepsy Therapeutics sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Addrenex Pharmaceuticals, Inc.
    Teva Pharmaceutical Industries Ltd.
    Jazz Pharmaceuticals PLC
    Graymark Healthcare, Inc.
    Arena Pharmaceuticals, Inc.
    BIOPROJET
    Shire
    Ligand Pharmaceuticals, Inc.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Central nervous system stimulants
    Sodium Oxybate
    Selective Serotonin Reuptake Inhibitor (SSRI)
    Tricyclic Antidepressants
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Narcolepsy With Cataplexy
    Narcolepsy Without Cataplexy
    Secondary Narcolepsy

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

EMEA (Europe, Middle East and Africa) Narcolepsy Therapeutics Market Report 2017
1 Narcolepsy Therapeutics Overview
    1.1 Product Overview and Scope of Narcolepsy Therapeutics
    1.2 Classification of Narcolepsy Therapeutics
        1.2.1 EMEA Narcolepsy Therapeutics Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Narcolepsy Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Central nervous system stimulants
        1.2.4 Sodium Oxybate
        1.2.5 Selective Serotonin Reuptake Inhibitor (SSRI)
        1.2.6 Tricyclic Antidepressants
        1.2.7 Others
    1.3 EMEA Narcolepsy Therapeutics Market by Application/End Users
        1.3.1 EMEA Narcolepsy Therapeutics Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Narcolepsy With Cataplexy
        1.3.3 Narcolepsy Without Cataplexy
        1.3.4 Secondary Narcolepsy
    1.4 EMEA Narcolepsy Therapeutics Market by Region
        1.4.1 EMEA Narcolepsy Therapeutics Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Narcolepsy Therapeutics (2012-2022)
        1.5.1 EMEA Narcolepsy Therapeutics Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Narcolepsy Therapeutics Revenue and Growth Rate (2012-2022)

2 EMEA Narcolepsy Therapeutics Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Narcolepsy Therapeutics Market Competition by Players/Manufacturers
        2.1.1 EMEA Narcolepsy Therapeutics Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Narcolepsy Therapeutics Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Narcolepsy Therapeutics Sale Price by Players (2012-2017)
    2.2 EMEA Narcolepsy Therapeutics (Volume and Value) by Type/Product Category
        2.2.1 EMEA Narcolepsy Therapeutics Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Narcolepsy Therapeutics Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Narcolepsy Therapeutics Sale Price by Type (2012-2017)
    2.3 EMEA Narcolepsy Therapeutics (Volume) by Application
    2.4 EMEA Narcolepsy Therapeutics (Volume and Value) by Region
        2.4.1 EMEA Narcolepsy Therapeutics Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Narcolepsy Therapeutics Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Narcolepsy Therapeutics Sales Price by Region (2012-2017)

3 Europe Narcolepsy Therapeutics (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Narcolepsy Therapeutics Sales and Value (2012-2017)
        3.1.1 Europe Narcolepsy Therapeutics Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Narcolepsy Therapeutics Revenue and Growth Rate (2012-2017)
    3.2 Europe Narcolepsy Therapeutics Sales and Market Share by Type
    3.3 Europe Narcolepsy Therapeutics Sales and Market Share by Application
    3.4 Europe Narcolepsy Therapeutics Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Narcolepsy Therapeutics Sales Volume by Countries (2012-2017)
        3.4.2 Europe Narcolepsy Therapeutics Revenue by Countries (2012-2017)
        3.4.3 Germany Narcolepsy Therapeutics Sales and Growth Rate (2012-2017)
        3.4.4 France Narcolepsy Therapeutics Sales and Growth Rate (2012-2017)
        3.4.5 UK Narcolepsy Therapeutics Sales and Growth Rate (2012-2017)
        3.4.6 Russia Narcolepsy Therapeutics Sales and Growth Rate (2012-2017)
        3.4.7 Italy Narcolepsy Therapeutics Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Narcolepsy Therapeutics Sales and Growth Rate (2012-2017)

4 Middle East Narcolepsy Therapeutics (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Narcolepsy Therapeutics Sales and Value (2012-2017)
        4.1.1 Middle East Narcolepsy Therapeutics Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Narcolepsy Therapeutics Revenue and Growth Rate (2012-2017)
    4.2 Middle East Narcolepsy Therapeutics Sales and Market Share by Type
    4.3 Middle East Narcolepsy Therapeutics Sales and Market Share by Application
    4.4 Middle East Narcolepsy Therapeutics Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Narcolepsy Therapeutics Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Narcolepsy Therapeutics Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Narcolepsy Therapeutics Sales and Growth Rate (2012-2017)
        4.4.4 Israel Narcolepsy Therapeutics Sales and Growth Rate (2012-2017)
        4.4.5 UAE Narcolepsy Therapeutics Sales and Growth Rate (2012-2017)
        4.4.6 Iran Narcolepsy Therapeutics Sales and Growth Rate (2012-2017)

5 Africa Narcolepsy Therapeutics (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Narcolepsy Therapeutics Sales and Value (2012-2017)
        5.1.1 Africa Narcolepsy Therapeutics Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Narcolepsy Therapeutics Revenue and Growth Rate (2012-2017)
    5.2 Africa Narcolepsy Therapeutics Sales and Market Share by Type
    5.3 Africa Narcolepsy Therapeutics Sales and Market Share by Application
    5.4 Africa Narcolepsy Therapeutics Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Narcolepsy Therapeutics Sales Volume by Countries (2012-2017)
        5.4.2 Africa Narcolepsy Therapeutics Revenue by Countries (2012-2017)
        5.4.3 South Africa Narcolepsy Therapeutics Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Narcolepsy Therapeutics Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Narcolepsy Therapeutics Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Narcolepsy Therapeutics Sales and Growth Rate (2012-2017)

6 EMEA Narcolepsy Therapeutics Manufacturers/Players Profiles and Sales Data
    6.1 Addrenex Pharmaceuticals, Inc.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Narcolepsy Therapeutics Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Teva Pharmaceutical Industries Ltd.
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Narcolepsy Therapeutics Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Jazz Pharmaceuticals PLC
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Narcolepsy Therapeutics Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Graymark Healthcare, Inc.
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Narcolepsy Therapeutics Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Graymark Healthcare, Inc. Narcolepsy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Arena Pharmaceuticals, Inc.
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Narcolepsy Therapeutics Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 BIOPROJET
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Narcolepsy Therapeutics Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 BIOPROJET Narcolepsy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Shire
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Narcolepsy Therapeutics Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Shire Narcolepsy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Ligand Pharmaceuticals, Inc.
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Narcolepsy Therapeutics Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview

7 Narcolepsy Therapeutics Manufacturing Cost Analysis
    7.1 Narcolepsy Therapeutics Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Narcolepsy Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Narcolepsy Therapeutics Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Narcolepsy Therapeutics Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Narcolepsy Therapeutics Market Forecast (2017-2022)
    11.1 EMEA Narcolepsy Therapeutics Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Narcolepsy Therapeutics Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Narcolepsy Therapeutics Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Narcolepsy Therapeutics Price and Trend Forecast (2017-2022)
    11.2 EMEA Narcolepsy Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Narcolepsy Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Narcolepsy Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Narcolepsy Therapeutics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Narcolepsy Therapeutics Sales Forecast by Type (2017-2022)
    11.7 EMEA Narcolepsy Therapeutics Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Figure Product Picture of Narcolepsy Therapeutics
    Figure EMEA Narcolepsy Therapeutics Sales Volume (K Pcs) by Type (2012-2022)
    Figure EMEA Narcolepsy Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
    Figure Central nervous system stimulants Product Picture
    Figure Sodium Oxybate Product Picture
    Figure Selective Serotonin Reuptake Inhibitor (SSRI) Product Picture
    Figure Tricyclic Antidepressants Product Picture
    Figure Others Product Picture
    Figure EMEA Narcolepsy Therapeutics Sales Volume (K Pcs) by Application (2012-2022)
    Figure EMEA Sales Market Share of Narcolepsy Therapeutics by Application in 2016
    Figure Narcolepsy With Cataplexy Examples
    Table Key Downstream Customer in Narcolepsy With Cataplexy
    Figure Narcolepsy Without Cataplexy Examples
    Table Key Downstream Customer in Narcolepsy Without Cataplexy
    Figure Secondary Narcolepsy Examples
    Table Key Downstream Customer in Secondary Narcolepsy
    Figure EMEA Narcolepsy Therapeutics Market Size (Million USD) by Region (2012-2022)
    Figure Europe Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Europe Narcolepsy Therapeutics Revenue (Million USD) Status and Forecast by Countries
    Figure Middle East Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Middle East Narcolepsy Therapeutics Revenue (Million USD) Status and Forecast by Countries
    Figure Africa Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Africa Narcolepsy Therapeutics Revenue (Million USD) Status and Forecast by Countries
    Figure EMEA Narcolepsy Therapeutics Sales Volume and Growth Rate (2012-2022)
    Figure EMEA Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
    Figure EMEA Narcolepsy Therapeutics Market Major Players Product Sales Volume (K Pcs) (2012-2017)
    Table EMEA Narcolepsy Therapeutics Sales Volume (K Pcs) of Major Players (2012-2017)
    Table EMEA Narcolepsy Therapeutics Sales Share by Players (2012-2017)
    Figure 2016 Narcolepsy Therapeutics Sales Share by Players
    Figure 2017 Narcolepsy Therapeutics Sales Share by Players
    Figure EMEA Narcolepsy Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017)
    Table EMEA Narcolepsy Therapeutics Revenue (Million USD) by Players (2012-2017)
    Table EMEA Narcolepsy Therapeutics Revenue Share by Players (2012-2017)
    Table 2016 EMEA Narcolepsy Therapeutics Revenue Share by Players
    Table 2017 EMEA Narcolepsy Therapeutics Revenue Share by Players
    Table EMEA Narcolepsy Therapeutics Sale Price (USD/Pcs) by Players (2012-2017)
    Table EMEA Narcolepsy Therapeutics Sales (K Pcs) and Market Share by Type (2012-2017)
    Table EMEA Narcolepsy Therapeutics Sales Share by Type (2012-2017)
    Figure Sales Market Share of Narcolepsy Therapeutics by Type (2012-2017)
    Figure EMEA Narcolepsy Therapeutics Sales Market Share by Type (2012-2017)
    Table EMEA Narcolepsy Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
    Table EMEA Narcolepsy Therapeutics Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Narcolepsy Therapeutics by Type in 2016
    Table EMEA Narcolepsy Therapeutics Sale Price (USD/Pcs) by Type (2012-2017)
    Table EMEA Narcolepsy Therapeutics Sales (K Pcs) and Market Share by Application (2012-2017)
    Table EMEA Narcolepsy Therapeutics Sales Share by Application (2012-2017)
    Figure Sales Market Share of Narcolepsy Therapeutics by Application (2012-2017)
    Figure EMEA Narcolepsy Therapeutics Sales Market Share by Application in 2016
    Table EMEA Narcolepsy Therapeutics Sales (K Pcs) and Market Share by Region (2012-2017)
    Table EMEA Narcolepsy Therapeutics Sales Share by Region (2012-2017)
    Figure Sales Market Share of Narcolepsy Therapeutics by Region (2012-2017)
    Figure EMEA Narcolepsy Therapeutics Sales Market Share in 2016
    Table EMEA Narcolepsy Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
    Table EMEA Narcolepsy Therapeutics Revenue Share by Region (2012-2017)
    Figure Revenue Market Share of Narcolepsy Therapeutics by Region (2012-2017)
    Figure EMEA Narcolepsy Therapeutics Revenue Market Share Regions in 2016
    Table EMEA Narcolepsy Therapeutics Sales Price (USD/Pcs) by Region (2012-2017)
    Figure Europe Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Europe Narcolepsy Therapeutics Revenue and Growth Rate (2012-2017)
    Table Europe Narcolepsy Therapeutics Sales (K Pcs) by Type (2012-2017)
    Table Europe Narcolepsy Therapeutics Market Share by Type (2012-2017)
    Figure Europe Narcolepsy Therapeutics Market Share by Type in 2016
    Table Europe Narcolepsy Therapeutics Sales (K Pcs) by Application (2012-2017)
    Table Europe Narcolepsy Therapeutics Market Share by Application (2012-2017)
    Figure Europe Narcolepsy Therapeutics Market Share by Application in 2016
    Table Europe Narcolepsy Therapeutics Sales (K Pcs) by Countries (2012-2017)
    Table Europe Narcolepsy Therapeutics Sales Market Share by Countries (2012-2017)
    Figure Europe Narcolepsy Therapeutics Sales Market Share by Countries (2012-2017)
    Figure Europe Narcolepsy Therapeutics Sales Market Share by Countries in 2016
    Table Europe Narcolepsy Therapeutics Revenue (Million USD) by Countries (2012-2017)
    Table Europe Narcolepsy Therapeutics Revenue Market Share by Countries (2012-2017)
    Figure Europe Narcolepsy Therapeutics Revenue Market Share by Countries (2012-2017)
    Figure Europe Narcolepsy Therapeutics Revenue Market Share by Countries in 2016
    Figure Germany Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure France Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure UK Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Russia Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Italy Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Benelux Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Middle East Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Middle East Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
    Table Middle East Narcolepsy Therapeutics Sales (K Pcs) by Type (2012-2017)
    Table Middle East Narcolepsy Therapeutics Market Share by Type (2012-2017)
    Figure Middle East Narcolepsy Therapeutics Market Share by Type (2012-2017)
    Table Middle East Narcolepsy Therapeutics Sales (K Pcs) by Applications (2012-2017)
    Table Middle East Narcolepsy Therapeutics Market Share by Applications (2012-2017)
    Figure Middle East Narcolepsy Therapeutics Sales Market Share by Application in 2016
    Table Middle East Narcolepsy Therapeutics Sales Volume (K Pcs) by Countries (2012-2017)
    Table Middle East Narcolepsy Therapeutics Sales Volume Market Share by Countries (2012-2017)
    Figure Middle East Narcolepsy Therapeutics Sales Volume Market Share by Countries in 2016
    Table Middle East Narcolepsy Therapeutics Revenue (Million USD) by Countries (2012-2017)
    Table Middle East Narcolepsy Therapeutics Revenue Market Share by Countries (2012-2017)
    Figure Middle East Narcolepsy Therapeutics Revenue Market Share by Countries (2012-2017)
    Figure Middle East Narcolepsy Therapeutics Revenue Market Share by Countries in 2016
    Figure Saudi Arabia Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Israel Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure UAE Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Iran Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Africa Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Africa Narcolepsy Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
    Table Africa Narcolepsy Therapeutics Sales (K Pcs) by Type (2012-2017)
    Table Africa Narcolepsy Therapeutics Sales Market Share by Type (2012-2017)
    Figure Africa Narcolepsy Therapeutics Sales Market Share by Type (2012-2017)
    Figure Africa Narcolepsy Therapeutics Sales Market Share by Type in 2016
    Table Africa Narcolepsy Therapeutics Sales (K Pcs) by Application (2012-2017)
    Table Africa Narcolepsy Therapeutics Sales Market Share by Application (2012-2017)
    Figure Africa Narcolepsy Therapeutics Sales Market Share by Application (2012-2017)
    Table Africa Narcolepsy Therapeutics Sales Volume (K Pcs) by Countries (2012-2017)
    Table Africa Narcolepsy Therapeutics Sales Market Share by Countries (2012-2017)
    Figure Africa Narcolepsy Therapeutics Sales Market Share by Countries (2012-2017)
    Figure Africa Narcolepsy Therapeutics Sales Market Share by Countries in 2016
    Table Africa Narcolepsy Therapeutics Revenue (Million USD) by Countries (2012-2017)
    Table Africa Narcolepsy Therapeutics Revenue Market Share by Countries (2012-2017)
    Figure Africa Narcolepsy Therapeutics Revenue Market Share by Countries (2012-2017)
    Figure Africa Narcolepsy Therapeutics Revenue Market Share by Countries in 2016
    Figure South Africa Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Nigeria Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Egypt Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Algeria Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Table Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Basic Information List
    Table Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Sales Market Share in EMEA (2012-2017)
    Figure Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue Market Share in EMEA (2012-2017)
    Table Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Basic Information List
    Table Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Sales Market Share in EMEA (2012-2017)
    Figure Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Revenue Market Share in EMEA (2012-2017)
    Table Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Basic Information List
    Table Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Sales Market Share in EMEA (2012-2017)
    Figure Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Revenue Market Share in EMEA (2012-2017)
    Table Graymark Healthcare, Inc. Narcolepsy Therapeutics Basic Information List
    Table Graymark Healthcare, Inc. Narcolepsy Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Graymark Healthcare, Inc. Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Graymark Healthcare, Inc. Narcolepsy Therapeutics Sales Market Share in EMEA (2012-2017)
    Figure Graymark Healthcare, Inc. Narcolepsy Therapeutics Revenue Market Share in EMEA (2012-2017)
    Table Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Basic Information List
    Table Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Sales Market Share in EMEA (2012-2017)
    Figure Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue Market Share in EMEA (2012-2017)
    Table BIOPROJET Narcolepsy Therapeutics Basic Information List
    Table BIOPROJET Narcolepsy Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure BIOPROJET Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure BIOPROJET Narcolepsy Therapeutics Sales Market Share in EMEA (2012-2017)
    Figure BIOPROJET Narcolepsy Therapeutics Revenue Market Share in EMEA (2012-2017)
    Table Shire Narcolepsy Therapeutics Basic Information List
    Table Shire Narcolepsy Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Shire Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Shire Narcolepsy Therapeutics Sales Market Share in EMEA (2012-2017)
    Figure Shire Narcolepsy Therapeutics Revenue Market Share in EMEA (2012-2017)
    Table Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Basic Information List
    Table Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
    Figure Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate (2012-2017)
    Figure Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Sales Market Share in EMEA (2012-2017)
    Figure Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue Market Share in EMEA (2012-2017)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Narcolepsy Therapeutics
    Figure Manufacturing Process Analysis of Narcolepsy Therapeutics
    Figure Narcolepsy Therapeutics Industrial Chain Analysis
    Table Raw Materials Sources of Narcolepsy Therapeutics Major Manufacturers in 2016
    Table Major Buyers of Narcolepsy Therapeutics
    Table Distributors/Traders List
    Figure EMEA Narcolepsy Therapeutics Sales (K Pcs) and Growth Rate Forecast (2017-2022)
    Figure EMEA Narcolepsy Therapeutics Revenue and Growth Rate Forecast (2017-2022)
    Figure EMEA Narcolepsy Therapeutics Price (USD/Pcs) and Trend Forecast (2017-2022)
    Table EMEA Narcolepsy Therapeutics Sales (K Pcs) Forecast by Region (2017-2022)
    Figure EMEA Narcolepsy Therapeutics Sales Market Share Forecast by Region (2017-2022)
    Table EMEA Narcolepsy Therapeutics Revenue (Million USD) Forecast by Region (2017-2022)
    Figure EMEA Narcolepsy Therapeutics Revenue Market Share Forecast by Region (2017-2022)
    Table Europe Narcolepsy Therapeutics Sales (K Pcs) Forecast by Countries (2017-2022)
    Figure Europe Narcolepsy Therapeutics Sales Market Share Forecast by Countries (2017-2022)
    Table Europe Narcolepsy Therapeutics Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Europe Narcolepsy Therapeutics Revenue Market Share Forecast by Countries (2017-2022)
    Table Middle East Narcolepsy Therapeutics Sales (K Pcs) Forecast by Countries (2017-2022)
    Figure Middle East Narcolepsy Therapeutics Sales Market Share Forecast by Countries (2017-2022)
    Table Middle East Narcolepsy Therapeutics Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Middle East Narcolepsy Therapeutics Revenue Market Share Forecast by Countries (2017-2022)
    Table Africa Narcolepsy Therapeutics Sales (K Pcs) Forecast by Countries (2017-2022)
    Figure Africa Narcolepsy Therapeutics Sales Market Share Forecast by Countries (2017-2022)
    Table Africa Narcolepsy Therapeutics Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Africa Narcolepsy Therapeutics Revenue Market Share Forecast by Countries (2017-2022)
    Table EMEA Narcolepsy Therapeutics Sales (K Pcs) Forecast by Type (2017-2022)
    Figure EMEA Narcolepsy Therapeutics Sales Market Share Forecast by Type (2017-2022)
    Table EMEA Narcolepsy Therapeutics Sales (K Pcs) Forecast by Application (2017-2022)
    Figure EMEA Narcolepsy Therapeutics Sales Market Share Forecast by Application (2017-2022)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources